In Utero Procedure Affecting Fetus or Newborn

2

Review clinical trials related to In Utero Procedure Affecting Fetus or Newborn. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Use of Karl Storz Curved Fetoscope (11508aak) and Its Straight Version (11506akk) for In-utero Surgery

The purpose of this study is to prospectively evaluate the efficacy of KARL STORZ curved fetoscope (11508AAK) and its straight version (11506AAK) for in-utero surgery

Participants needed: 50
Trial details
Age: 18-45Biological sex: FemaleType: InterventionalSponsor: The University of Texas Health Science Center, HoustonUpdated: Aug 14, 2025Locations: 1
Eligibility criteria

Pregnant woman [+2]

Contraindication to abdominal surgery, fetoscopic surgery, or general anesthesia [+6]

Status: Recruiting

A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures

In this research study, the investigators want to learn more about the role of new innovative surgical devices, the Karl Storz Curved and Straight Fetoscopes for in-utero surgery. A fetoscope is like a small telescope that can see inside of the uterus (womb) during minimally invasive surgery. The curved scope is used for patients with an anterior placenta (front of uterus), while the straight scope is used for patients with a posterior placenta (back of uterus). The scopes will be used to assist in procedures involving fetoscopic laser photocoagulation (FLP), which is a minimally invasive surgery that uses a small camera (fetoscope) to locate abnormal blood vessel connections in the placenta and seal them off using laser energy. These fetoscopes will be utilized in the diagnosis and management of various fetal conditions that can arise during pregnancy. Outcome data will be reported in a descriptive statistical analysis. The investigators will assess the surgical outcomes, short and long-term morbidity, complications, and gestational age of participants in order to evaluate the benefit of using these devices.

Participants needed: 50
Trial details
Age: 18-45Biological sex: FemaleType: InterventionalSponsor: Boston Children's HospitalUpdated: Sep 25, 2024Locations: 1
Eligibility criteria

Pregnant patient with a condition requiring in-utero surgery [+2]

Allergy or previous adverse reaction to any ancillary medication specified in th... [+6]